Form 4: Iron Mountain CEO Sells Shares Under 10b5-1 Plan

Iron Mountain Incorporated CEO William L. Meaney has reported the sale of company stock totaling over $1.5 million through a pre-arranged trading plan.

Summary

• William L. Meaney, President and CEO of Iron Mountain Incorporated, has reported transactions involving the sale of common stock.
• These sales occurred on June 1, 2026, and were executed under a Rule 10b5-1 trading plan adopted on March 14, 2025.
• The total number of shares sold across various transactions is 66,730.
• The sales generated proceeds totaling approximately $7.9 million, with weighted average prices ranging from $126.20 to $129.66.
• Following these transactions, Mr. Meaney's direct beneficial ownership of common stock has decreased, while indirect ownership remains significant.
• Mr. Meaney also holds a vested employee stock option for 38,474 shares.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing as neutral to slightly negative due to the significant volume of shares sold by the CEO, despite being executed under a 10b5-1 plan.

Positives

• The transactions were conducted under a Rule 10b5-1 plan, indicating pre-planned and potentially non-insider trading related sales.
• The sales occurred at prices generally above $126 per share, reflecting a relatively strong market valuation at the time of the transactions.
• Mr. Meaney retains a significant number of shares and an exercisable stock option, suggesting continued commitment to the company.

Negatives

• A substantial number of shares (66,730) were sold by the CEO, which could be perceived negatively by the market.
• The total value of shares sold is over $7.9 million, representing a significant divestment by a key executive.

Risks

• Potential for negative market perception due to the CEO's significant share sales, even if conducted under a 10b5-1 plan.
• Future stock price performance could be impacted if the market interprets these sales as a lack of confidence by management.

Future Outlook

The filing itself does not contain forward-looking statements or guidance. It reports on past transactions.

Management Comments

• The transactions were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.
• The Reporting Person undertakes to provide Iron Mountain Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in the footnotes.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine for executives and directors, often related to pre-scheduled trading plans like Rule 10b5-1, which are designed to allow insiders to sell stock without facing insider trading accusations. The volume and timing of such sales can still influence market perception.

Stakeholder Impact

• Shareholders: May view the CEO's significant stock sale with concern, potentially impacting short-term stock price sentiment.
• Employees: May interpret the sale as a signal from leadership, though the 10b5-1 plan mitigates direct insider trading concerns.
• Creditors: Unlikely to be directly impacted by this executive stock transaction.

Next Steps

• The reporting person may be required to provide further details on specific sale prices upon request from the SEC, company, or security holders.

Key Dates

Recommendation

While the sale of a significant number of shares by the CEO could be a short-term negative signal, the fact that it was executed under a Rule 10b5-1 plan suggests it was pre-planned and not necessarily indicative of a lack of confidence in the company's future. The company's underlying fundamentals and future prospects, not detailed in this specific filing, would be the primary drivers for a buy/sell/hold decision. Therefore, a 'hold' recommendation is appropriate pending further information.

Keywords

Form 4, SEC Filing, Insider Trading, Rule 10b5-1, William L. Meaney, Iron Mountain, IRM, Stock Sale, Beneficial Ownership, Executive Compensation